School of Medicine
Showing 1-4 of 4 Results
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
Bio Jeff Kleck (Menlo Park, CA) is an Adjunct Professor in the School of Medicine. He is also one of the Silicon Valley's leading healthcare technology and software entrepreneurs. He was most recently President of iSchemaView (privately held). Before building iSchemaView he was Founder and the CEO and Chairman of Attainia (acquired by private equity). Prior to Attainia he was Founder and the CEO and Chairman of Neoforma (NASDAQ: NEOF), which was purchased by GHX (privately held). Before Neoforma he held two management positions at Varian (NYSE: VAR). Dr. Kleck holds a PhD in Biomedical Physics from UCLA (former faculty), an MS in Engineering Management from Stanford University (current faculty), and an MS and a BS in Nuclear Engineering from Texas A&M University (current advisor). He also holds numerous certifications, licenses, and patents.
Shivaani Kummar, MD, FACP
Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Kummar’s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.